IFNg-induced Irgm1 promotes tumorigenesis of melanoma via dual regulation of apoptosis and Bif-1-dependent autophagy

Oncogene

Volumn 34, Issue 42, 2015, Pages 5363-5371

  Dong, H ^a,b   Tian, L ^a   Li, R ^c   Pei, C ^a   Fu, Y ^a   Dong, X ^a   Xia, F ^a   Wang, C ^a,b   Li, W ^a   Guo, X ^a   Gu, C ^a   Li, B ^a   Liu, A ^a   Ren, H ^a   Xu, H ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b FUJIAN MEDICAL UNIVERSITY   (China)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BAX INTERACTING FACTOR 1; CARRIER PROTEINS AND BINDING PROTEINS; CASPASE 3; ENDOPHILIN; GAMMA INTERFERON; GUANOSINE TRIPHOSPHATASE; IMMUNITY RELATED GUANOSINE TRIPHOSPHATASE FAMILY MEMBER 1; PROTEIN BAK; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; GUANINE NUCLEOTIDE BINDING PROTEIN; IFI1 PROTEIN, MOUSE; IRGM PROTEIN, HUMAN; SH3GLB1 PROTEIN, HUMAN; SH3GLB1 PROTEIN, MOUSE; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

APOPTOSIS; ARTICLE; AUTOPHAGY; CARCINOGENESIS; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOSURVEILLANCE; IN VITRO STUDY; MELANOMA; PRIORITY JOURNAL; PROTEIN LOCALIZATION; TUMOR BIOPSY; TUMOR GROWTH; ANIMAL; C57BL MOUSE; MOUSE; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; APOPTOSIS; AUTOPHAGY; CELL LINE, TUMOR; CELL SURVIVAL; GTP-BINDING PROTEINS; HUMANS; INTERFERON-GAMMA; MELANOMA; MICE; MICE, INBRED C57BL;

EID: 84945451398     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2014.459     Document Type: Article

References (34)

1. Ikeda H, Old LJ, Schreiber RD. The roles of IFN gamma in protection against tumor development and cancer immunoediting. Cytokine Growth Factor Rev 2002; 13: 95-109.
2. Dighe AS, Richards E, Old LJ, Schreiber RD. Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN ? receptors. Immunity 1994; 1: 447-456.
3. Kaplan DH, Shankaran V, Dighe AS, Stockert E, Aguet M, Old LJ et al. Demonstration of an interferon ?-dependent tumor surveillance system in immunocompetent mice. Proc Natl Acad Sci USA 1998; 95: 7556-7561.
4. Street SE, Trapani JA, MacGregor D, Smyth MJ. Suppression of lymphoma and epithelial malignancies effected by interferon ?. J Exp Med 2002; 196: 129-134.
5. Street SE, Cretney E, Smyth MJ. Perforin and interferon-? activities independently control tumor initiation, growth, and metastasis. Blood 2001; 97: 192-197.
6. Boehm U, Klamp T, Groot M, Howard JC. Cellular responses to interferon-?. Annu Rev Immunol 1997; 15: 749-795.
7. Seliger B, Ruiz-Cabello F, Garrido F. IFN inducibility of major histocompatibility antigens in tumors. Adv Cancer Res 2008; 101: 249-276.
8. Brown TJ, Lioubin MN, Marquardt H. Purification and characterization of cytostatic lymphokines produced by activated human T lymphocytes. Synergistic antiproliferative activity of transforming growth factor beta 1, interferongamma, and oncostatin M for human melanoma cells. J Immunol 1987; 139: 2977-2983.
9. Taniguchi K, Petersson M, Höglund P, Kiessling R, Klein G, Kärre K. Interferon gamma induces lung colonization by intravenously inoculated B16 melanoma cells in parallel with enhanced expression of class I major histocompatibility complex antigens. Proc Natl Acad Sci USA 1987; 84: 3405-3409.
10. He YF, Wang XH, Zhang GM, Chen HT, Zhang H, Feng ZH. Sustained low-level expression of interferon-gamma promotes tumor development: potential insights in tumor prevention and tumor immunotherapy. Cancer Immunol Immunother 2005; 54: 891-897.
11. Zaidi MR, Davis S, Noonan FP, Graff-Cherry C, Hawley TS, Walker RL et al. Interferon-? links ultraviolet radiation to melanomagenesis in mice. Nature 2011; 469: 548-553.
12. Lollini PL, Bosco MC, Cavallo F, De Giovanni C, Giovarelli M, Landuzzi L et al. Inhibition of tumor growth and enhancement of metastasis after transfection of the gamma-interferon gene. Int J Cancer 1993; 55: 320-329.
13. Bernabei P, Coccia EM, Rigamonti L, Bosticardo M, Forni G, Pestka S et al. Interferon-gamma receptor 2 expression as the deciding factor in human T, B, and myeloid cell proliferation or death. J Leukoc Biol 2001; 70: 950-960.
14. Taylor GA, Jeffers M, Largaespada DA, Jenkins NA, Copeland NG, Woude GF. Identification of a novel GTPase, the inducibly expressed GTPase, that accumulates in response to interferon gamma. J Biol Chem 1996; 271: 20399-20405.
15. Singh SB, Davis AS, Taylor GA, Deretic V. Human IRGM induces autophagy to eliminate intracellular mycobacteria. Science 2006; 8: 1438-1441.
16. Tiwari S, Choi HP, Matsuzawa T, Pypaert M, MacMicking JD. Targeting of the GTPase Irgm1 to the phagosomal membrane via PtdIns(3,4)P(2) and PtdIns(3,4,5)P(3) promotes immunity to mycobacteria. Nat Immunol 2009; 10: 907-917.
17. Feng CG, Weksberg DC, Taylor GA, Sher A, Goodell MA. The p47 GTPase Lrg-47 (Irgm1) links host defense and hematopoietic stem cell proliferation. Cell Stem Cell 2008; 2: 83-89.
18. Xia F, Li R, Wang C, Yang S, Tian L, Dong H et al. Irgm1 regulates oxidized LDL uptake by macrophage via actin-dependent receptor internalization during atherosclerosis. Sci Rep 2013; 3: 1867.
19. Xu H, Wu ZY, Fang F, Guo L, Chen D, Chen JX et al. Genetic deficiency of Irgm1 (LRG-47) suppresses induction of experimental autoimmune encephalomyelitis by promoting apoptosis of activated CD4+ T cells. FASEB J 2010; 24: 1583-1592.
20. He S, Wang C, Dong H, Xia F, Zhou H, Jiang X et al. Immune-related GTPase M (Irgm1) regulates neuronal autophagy in a mouse model of stroke. Autophagy 2012; 8: 1621-1627.
21. Degenhardt K, Mathew R, Beaudoin B, Bray K, Anderson D, Chen G et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 2006; 10: 51-64.
22. Guo JY, Xia B, White E. Autophagy-mediated tumor promotion. Cell 2013; 155: 1216-1219.
23. Altman BJ, Rathmell JC. Autophagy: not good OR bad, but good AND bad. Autophagy 2009; 5: 569-570.
24. Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012; 8: 445-544.
25. Takahashi Y, Karbowski M, Yamaguchi H, Kazi A, Wu J, Sebti S et al. Loss of Bif-1 suppresses Bax/Bak conformational change and mitochondrial apoptosis. Mol Cell Biol 2005; 25: 9369-9382.
26. Takahashi Y, Coppola D, Matsushita N, Cualing HD, Sun M, Sato Y et al. Bif-1 interacts with Beclin 1 through UVRAG and regulates autophagy and tumorigenesis. Nat Cell Biol 2007; 9: 1142-1151.
27. Takahashi Y, Meyerkord CL, Wang HG. BARgaining membranes for autophagosome formation: regulation of autophagy and tumorigenesis by Bif-1/Endophilin B1. Autophagy 2008; 4: 121-124.
28. Takahashi Y, Meyerkord CL, Wang HG. Bif-1/endophilin B1: candidate for crescent driving force in autophagy. Cell Death Differ 2009; 16: 947-955.
29. Feng CG, Zheng L, Jankovic D, Báfica A, Cannons JL, Watford WT et al. The immunity-related GTPase Irgm1 promotes the expansion of activated CD4+ T cell populations by preventing interferon-gamma-induced cell death. Nat Immunol 2008; 9: 1279-1287.
30. Wang Y, Liu DP, Chen PP, Koeffler HP, Tong XJ, Xie D. Involvement of IFN regulatory factor (IRF)-1 and IRF-2 in the formation and progression of human esophageal cancers. Cancer Res 2007; 67: 2535-2543.
31. Yi Y, Wu H, Gao Q, He HW, Li YW, Cai XY et al. Interferon regulatory factor (IRF)-1 and IRF-2 are associated with prognosis and tumor invasion in HCC. Ann Surg Oncol 2013; 20: 267-276.
32. Yin X, Cao L, Kang R, Yang M, Wang Z, Peng Y et al. UV irradiation resistanceassociated gene suppresses apoptosis by interference with Bax activation. EMBO Rep 2011; 12: 727-734.
33. Liang C, Feng P, Ku B, Dotan I, Canaani D, Oh BH et al. Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG. Nat Cell Biol 2006; 8: 688-699.
34. Overwijk WW, Restifo NP. B16 as a mouse model for human melanoma. Curr Protoc Immunol 2001; Chapter 20: Unit 20.1.